Ningde Luyan Pharmaceutical Co., Ltd. announced that it will receive CNY 10,000,000 in an equity round of funding from returning investor Luyan Pharma Co.,Ltd. on October 27, 2021. Post closing, the registered capital of the company will increase from CNY 50,000,000 to CNY 60,000,000, and the investor will continue to hold 100% stake in the company. The transaction has been approved in the seventh meeting of the fifth board of directors of the investor, and is not subject to its shareholders' approval.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.04 CNY | -1.53% | +2.15% | +0.56% |
Apr. 15 | Luyan Pharma Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
2023 | Luyan Pharma Co.,Ltd. Announces Board Appointments | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+0.56% | 494M | |
+19.79% | 72.78B | |
-2.74% | 24.24B | |
+8.80% | 8.59B | |
+9.15% | 8.38B | |
-17.39% | 8.09B | |
+7.33% | 4.81B | |
+17.69% | 4.32B | |
-3.66% | 4.05B | |
-2.54% | 3.93B |
- Stock Market
- Equities
- 002788 Stock
- News Luyan Pharma Co.,Ltd.
- Ningde Luyan Pharmaceutical Co., Ltd. announced that it expects to receive CNY 10 million in funding from Luyan Pharma Co.,Ltd.